dichloromethylbenzene: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 7411 |
| CHEMBL ID | 1412576 |
| CHEBI ID | 82273 |
| SCHEMBL ID | 28353 |
| MeSH ID | M0101917 |
| Synonym |
|---|
| dichloromethylbenzene |
| M012 , |
| nsc7915 |
| benzylene chloride |
| benzene, (dichloromethyl)- |
| benzal chloride |
| benzylidene chloride |
| chlorure de benzylidene |
| .alpha.,.alpha.-dichlorotoluene |
| 98-87-3 |
| dichlorophenylmethane |
| wln: gygr |
| nsc-7915 |
| (dichloromethyl)benzene |
| benzyl dichloride |
| toluene, .alpha.,.alpha.-dichloro- |
| alpha,alpha-dichloro-toluene |
| inchi=1/c7h6cl2/c8-7(9)6-4-2-1-3-5-6/h1-5,7 |
| alpha,alpha-dichlorotoluene |
| NCGC00091362-01 |
| rcra waste number u017 |
| hsdb 5322 |
| rcra waste no. u017 |
| benzene, dichloromethyl- |
| un1886 |
| einecs 202-709-2 |
| ai3-28597 |
| ccris 959 |
| toluene, alpha,alpha-dichloro- |
| chlorobenzal |
| chlorure de benzylidene [french] |
| nsc 7915 |
| cloruro de bencilideno [spanish] |
| brn 1099407 |
| alpha,alpha-dichlorotoluene, 95% |
| b1414 , |
| benzylidene dichloride |
| FT-0694812 |
| NCGC00091362-03 |
| NCGC00091362-02 |
| C19165 |
| cas-98-87-3 |
| dtxcid405014 |
| tox21_300171 |
| dtxsid6025014 , |
| NCGC00254144-01 |
| tox21_201313 |
| NCGC00258865-01 |
| ec 249-854-8 |
| einecs 249-854-8 |
| 29797-40-8 |
| unii-222447tr16 |
| cloruro de bencilideno |
| 222447tr16 , |
| ec 202-709-2 |
| 4-05-00-00817 (beilstein handbook reference) |
| benzylidene chloride [un1886] [poison] |
| AKOS015902605 |
| benzal chloride [hsdb] |
| benzal chloride [mi] |
| SCHEMBL28353 |
| chlorobenzyl chloride |
| 1-(dichloromethyl)benzene |
| CHEBI:82273 , |
| a,a-dichlorotoluene |
| mfcd00000829 |
| un 1886 |
| .alpha.,.alpha.-dichlortoluene |
| CHEMBL1412576 |
| alpha,alpha-dichlorotoluene, pestanal(r), analytical standard |
| benzalchlorid |
| alpha-alpha-dichlorotoluene |
| Q419420 |
| FS-4304 |
| benzal chloride??? |
| EN300-24496449 |
| alpha , alpha -dichlorotoluene |
| Class | Description |
|---|---|
| benzenes | Any benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 39.8107 | 0.0013 | 18.0743 | 39.8107 | AID926; AID938 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 78.2912 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 23.1515 | 0.0008 | 17.5051 | 59.3239 | AID1159527; AID1159531 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 56.2341 | 0.0010 | 19.4141 | 70.9645 | AID588537 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 68.5896 | 0.0007 | 23.0674 | 1,258.9301 | AID743085 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 58.8074 | 0.0006 | 27.2152 | 1,122.0200 | AID743202; AID743219 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (87.19) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||